Patent Reports Market Research
A global inventory of Patent Reports, details include Meloxicam, Fipronil, Zoledronic Acid and many more.
first
previous
Title  | Date  | Price |
|---|---|---|
| Paroxetine Pipeline Developer | Mar 2009 | £2,995 |
| Nebivolol Pipeline Developer | Mar 2009 | £2,545 |
| Nateglinide Pipeline Developer | Mar 2009 | £2,995 |
| Levocetirizine Pipeline Developer | Mar 2009 | £2,995 |
| Pegfilgrastim Pipeline Developer | Mar 2009 | £7,145 |
| Pemetrexed Pipeline Developer | Mar 2009 | £3,440 |
| Pioglitazone Pipeline Developer | Mar 2009 | £3,440 |
| Perindopril Pipeline Developer | Mar 2009 | £2,995 |
| Pergolide Pipeline Developer | Mar 2009 | £2,545 |
| Penciclovir Pipeline Developer | Mar 2009 | £3,440 |
| Levetiracetam Pipeline Developer | Mar 2009 | £2,995 |
| Lercanidipine Pipeline Developer | Mar 2009 | £2,995 |
| Lacidipine Pipeline Developer | Mar 2009 | £2,545 |
| Itraconazole Pipeline Developer | Mar 2009 | £3,440 |
| Isotretinoin Pipeline Developer | Mar 2009 | £2,995 |
| Adapalene Pipeline Developer | Mar 2009 | £2,995 |
| Lamivudine Pipeline Developer | Mar 2009 | £3,440 |
| Lamotrigine Pipeline Developer | Mar 2009 | £2,545 |
| Leflunomide Pipeline Developer | Mar 2009 | £2,545 |
| Latanoprost Pipeline Developer | Mar 2009 | £2,545 |
| Lapatinib Pipeline Developer | Mar 2009 | £2,995 |
| Lansoprazole Pipeline Developer | Mar 2009 | £2,995 |
| Pitavastatin Pipeline Developer | Mar 2009 | £3,440 |
| Posaconazole Pipeline Developer | Mar 2009 | £3,885 |
| Olopatadine Pipeline Developer | Mar 2009 | £2,995 |
| Modafinil Pipeline Developer | Mar 2009 | £2,995 |
| Olmesartan Pipeline Developer | Mar 2009 | £3,885 |
| Olanzapine Pipeline Developer | Mar 2009 | £2,995 |
| Dasatinib Pipeline Developer | Mar 2009 | £2,995 |
| Omega-3-acid ethyl esters Pipeline Developer | Mar 2009 | £4,735 |
| Oxaliplatin Pipeline Developer | Mar 2009 | £2,995 |
| Orlistat Pipeline Developer | Mar 2009 | £2,545 |
| Ondansetron Pipeline Developer | Mar 2009 | £2,545 |
| Omeprazole Pipeline Developer | Mar 2009 | £3,440 |
| Octreotide Pipeline Developer | Mar 2009 | £2,995 |
| Nicorandil Pipeline Developer | Mar 2009 | £2,545 |
| Docetaxel Pipeline Developer | Mar 2009 | £3,885 |
| Donepezil Pipeline Developer | Mar 2009 | £3,440 |
| Doramectin (Vet) Pipeline Developer | Mar 2009 | £3,440 |
| Doripenem Pipeline Developer | Mar 2009 | £3,440 |
| Desvenlafaxine Pipeline Developer | Mar 2009 | £2,995 |
| Desloratadine Pipeline Developer | Mar 2009 | £2,995 |
| Paclitaxel Pipeline Developer | Mar 2009 | £3,885 |
| Pantoprazole Pipeline Developer | Mar 2009 | £2,995 |
| Paricalcitol Pipeline Developer | Mar 2009 | £2,545 |
| Levofloxacin Pipeline Developer | Mar 2009 | £3,885 |
| Iron Sucrose Pipeline Developer | Mar 2009 | £3,440 |
| Alendronic Acid & Colecalciferol Pipeline Developer | Mar 2009 | £3,440 |
| Alendronic Acid Pipeline Developer | Mar 2009 | £2,995 |
| Adefovir Pipeline Developer | Mar 2009 | £3,440 |
| Alendronic Acid & Colecalciferol: Extended Country Coverage Pipeline Selector | Mar 2009 | £625 |
| Barnidipine Pipeline Developer | Mar 2009 | £3,440 |
| Azithromycin Pipeline Developer | Mar 2009 | £2,995 |
| Armodafinil Pipeline Developer | Mar 2009 | £2,995 |
| Atorvastatin Pipeline Developer | Mar 2009 | £3,440 |
| Atovaquone Pipeline Developer | Mar 2009 | £2,545 |
| Azelastine Pipeline Developer | Mar 2009 | £3,440 |
| Alendronic Acid & Colecalciferol: Core Country Coverage Pipeline Selector | Mar 2009 | £270 |
| Doxorubicin Pipeline Developer | Mar 2009 | £3,885 |
| Abacavir Pipeline Developer | Mar 2009 | £3,440 |
| Acarbose Pipeline Developer | Mar 2009 | £2,995 |
| Acitretin Pipeline Developer | Mar 2009 | £2,545 |
| Adalimumab Pipeline Developer | Mar 2009 | £4,425 |
| Tramadol & Paracetamol: Extended Country Coverage Pipeline Selector | Mar 2009 | £625 |
| Ivermectin & Praziquantel (Vet): Extended Country Coverage Pipeline Selector | Mar 2009 | £625 |
| Dorzolamide Pipeline Developer | Mar 2009 | £2,995 |
| Telmisartan Pipeline Developer | Mar 2009 | £3,885 |
| Letrozole Pipeline Developer | Mar 2009 | £2,995 |
| Linezolid Pipeline Developer | Mar 2009 | £3,440 |
| Aripiprazole Pipeline Developer | Mar 2009 | £3,440 |
| Mometasone Pipeline Developer | Mar 2009 | £2,995 |
| Mirtazapine Pipeline Developer | Mar 2009 | £2,545 |
| Midazolam Pipeline Developer | Mar 2009 | £2,545 |
| Anastrozole Pipeline Developer | Mar 2009 | £2,995 |
| Montelukast Pipeline Developer | Mar 2009 | £2,995 |
| Moxidectin (Vet) Pipeline Developer | Mar 2009 | £2,995 |
| Losartan Pipeline Developer | Mar 2009 | £3,885 |
| Naratriptan Pipeline Developer | Mar 2009 | £3,440 |
| Mycophenolic Acid Pipeline Developer | Mar 2009 | £2,995 |
| Moxifloxacin Pipeline Developer | Mar 2009 | £3,885 |
| Meropenem Pipeline Developer | Mar 2009 | £3,440 |
| Micafungin Pipeline Developer | Mar 2009 | £3,440 |
| Memantine Pipeline Developer | Mar 2009 | £2,100 |
| Almotriptan Pipeline Developer | Mar 2009 | £3,440 |
| Amorolfine Pipeline Developer | Mar 2009 | £2,545 |
| Amphotericin B Pipeline Developer | Mar 2009 | £4,425 |
| Alfuzosin Pipeline Developer | Mar 2009 | £2,545 |
| Aliskiren Pipeline Developer | Mar 2009 | £3,440 |
| Ivermectin & Praziquantel (Vet): Core Country Coverage Pipeline Selector | Mar 2009 | £270 |
| Meloxicam Pipeline Developer | Mar 2009 | £2,545 |
| Meloxicam (Vet) Pipeline Developer | Mar 2009 | £2,545 |
| Irinotecan Pipeline Developer | Mar 2009 | £3,440 |
| Footcare Products in the U.S. | May 2007 | £1,200 |
| Family Planning Centers in the US IBISWorld Industry Report | Apr 2007 | £390 |
| When Patients Becomes Plaintiffs A Primer on Drug and Medical Device Liability | Oct 2006 | £1,095 |
Filter Results by
Industry Events
2nd International Conference on Drug Discovery and Therapy
01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>
Advancing Biologics from the Lab to the Clinic
11 Jan 10 to 12 Jan 10
Brussels, Belgium
view summary >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
